The effects of tramadol on postoperative shivering after sevoflurane and remifentanil anesthesia

Nagao, Taku; Hashimoto, Miki; Hashimoto, Y; Shirozu, Kazuhiro; Hoka, Sumio

doi:10.1186/s12871-016-0295-x

Cited by 28 publications

(19 citation statements)

References 21 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Anesthesia and CPB were performed using procedures standard at the 2 institutions. [25,26] Briefly, anesthesia was induced with midazolam, sufentanil, and a muscle relaxant, which was usually etomidate at the Second Affiliated Hospital. Anesthesia was maintained with a continuous infusion of remifentanil, inhalation of sevoflurane, intermittent muscle relaxant, and sufentanil.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Risk of massive blood product requirement in cardiac surgery

et al. 2019

View full text Add to dashboard Cite

Cardiac surgery under cardiopulmonary bypass (CPB) accounts for most consumption of red blood cells (RBCs). Identifying risk factors for massive red blood cell transfusion (MRT) in cardiac surgery may help to reduce this consumption. We retrospectively analyzed 8238 patients who underwent valve surgery and/or coronary artery bypass grafting (CABG) under CPB at 2 major heart centers in China. Uni- and multivariate logistic regression was carried out to assess whether risk factors for MRT (defined as receiving at least 4 units RBCs) varied with type of cardiac surgery. A total of 1691 patients (21%) received at least 4 units RBCs (6.77 ± 4.78 units per person). This MRT group consumed 70% of the total units of allogeneic RBCs in the study. MRT incidence was 2-fold higher among patients undergoing CABG with or without valve surgery than among patients undergoing valve surgery alone. Multivariate logistic analysis identified the following MRT risk factors common to valve surgery alone, CABG alone, and their combination: female sex, older age, renal dysfunction, lower body mass index, lower preoperative hemoglobin, and longer CPB. Several independent MRT risk factors were also identified specific to valve surgery: active endocarditis, nonatrial fibrillation, smaller left atrium diameter, abnormal international normalized ratio, and repeat surgery. Different types of cardiac surgery share several, but not all, MRT risk factors. This study may help guide the prediction and management of patients at higher MRT risk.

show abstract

Section: Methodsmentioning

confidence: 99%

“…After CPB, residual blood was collected in a bag containing sodium citrate, neutralized by protamine, and transfused into the patient as described. [26,27]…”

Section: Methodsmentioning

confidence: 99%

Risk of massive blood product requirement in cardiac surgery

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Mohta et al also reported that tramadol 2 mg/kg provided an effective combination of anti-PS activity and analgesia without excessive sedation [43]. Nakagawa et al showed that the administration of tramadol (3 mg/kg) at induction of anaesthesia significantly reduced the incidence of PS independently of remifentanil concentration used intraoperatively [44]. Ketamine is a competitive antagonist at the NMDA receptor, suggesting that the antishivering effect of tramadol might be mediated by the NMDA receptor [44].…”

Section: Opioid Receptor Agonistsmentioning

confidence: 99%

Postanaesthetic shivering – from pathophysiology to prevention

López

2018

Rom J Anaesth Int Care

View full text Add to dashboard Cite

Postoperative shivering is a common complication of anaesthesia. Shivering is believed to increase oxygen consumption, increase the risk of hypoxemia, induce lactic acidosis, and catecholamine release. Therefore, it might increase the postoperative complications especially in high-risk patients. Moreover, shivering is one of the leading causes of discomfort for postsurgical patients. Shivering is usually triggered by hypothermia. However, it occurs even in normothermic patients during the perioperative period. The aetiology of shivering has been understood insufficiently. Another potential mechanism is pain and acute opioid withdrawal (especially with the use of short-acting narcotics). Besides that shivering is poorly understood, the gold standard for the treatment and prevention has not been defined yet. Perioperative hypothermia prevention is the first method to avoid shivering. Many therapeutic strategies for treating shivering exist and most are empiric. Unfortunately, the overall quality of the antishivering guidelines is low. Two main strategies are available: pharmacological and non-pharmacological antishivering methods. The combination of forced-air warming devices and intravenous meperidine is the most validated method. We also analysed different medications but final conclusion about the optimal antishivering medication is difficult to be drawn due to the lack of high-quality evidence. Nevertheless, control of PS is possible and clinically effective with simple pharmacological interventions combined with non pharmacological methods. However, to be consistent with the most up-to-date, evidence-based practice, future antishivering treatment protocols should optimize methodological rigor and transparency.

show abstract

“…There have been studies that investigated the performances of ProSeal™ LMA (Intavent Orthofix, Maidenhead, UK) in LC 3,4. However, the performances of i-Gel® and AuraGain have not yet been sufficiently investigated.…”

mentioning

confidence: 99%

AuraGain^™ and i-Gel^® laryngeal masks in general anesthesia for laparoscopic cholecystectomy

Sabuncu

Kuşderci

Öterkuş

et al. 2018

SMJ

View full text Add to dashboard Cite

Objectives:To evaluate and compare the performances of new types of supraglottic airway devices (SADs) with endotracheal intubation regarding their ease of insertions, perioperative complications, and effects on hemodynamic parameters and peak airway pressures in laparascopic cholecystectomy (LC).Methods:One hundred and fourteen patients with ASA 1-2 physical status scheduled for elective LC were recruited for this prospective randomized controlled trial. The study was completed between January 2016 and January 2017 in Adiyaman University Research and Educational Hospital, Adiyaman, Turkey. The patients were divided into AuraGain™ (Ambu, Ballerup, Denmark) (n=38), i-Gel® (Intersurgical Ltd, UK) (n=35), and endotracheal tube (ETT) (n=32) groups. Ease of insertion, airway pressures, complications, and hemodynamic variables were compared.Results:The trial was completed with 105 patients. Ease of insertion for SADs which was evaluated with insertion procedure duration, attempts, first insertion success rates, and oropharyngeal leak pressures were similar between the groups. Heart rate, systolic and diastolic arterial pressures, and peak airway pressures were significantly lower in the AuraGain and i-Gel® groups, compared with the ETT, p<0.017.Conclusion:Both AuraGain and i-Gel® SADs are comparable with ETT used for airway control in general anesthesia for LC, regarding application ease and perioperative complications. Favorable hemodynamic responses to AuraGain and i-Gel® SADs may put them in a better place than ETT.

show abstract

The effects of tramadol on postoperative shivering after sevoflurane and remifentanil anesthesia

Cited by 28 publications

References 21 publications

Risk of massive blood product requirement in cardiac surgery

Risk of massive blood product requirement in cardiac surgery

Postanaesthetic shivering – from pathophysiology to prevention

AuraGain^™ and i-Gel^® laryngeal masks in general anesthesia for laparoscopic cholecystectomy

Contact Info

Product

Resources

About

The effects of tramadol on postoperative shivering after sevoflurane and remifentanil anesthesia

Cited by 28 publications

References 21 publications

Risk of massive blood product requirement in cardiac surgery

Risk of massive blood product requirement in cardiac surgery

Postanaesthetic shivering – from pathophysiology to prevention

AuraGain™ and i-Gel® laryngeal masks in general anesthesia for laparoscopic cholecystectomy

Contact Info

Product

Resources

About

AuraGain^™ and i-Gel^® laryngeal masks in general anesthesia for laparoscopic cholecystectomy